Crown Bioscience Inc.
Laurie Heilmann Named President of New CrownBio Global Life Science and Diagnostic Solutions Division
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, today announces the appointment of Laurie Heilmann as President of CrownBio Global Life Science Product and Diagnostic Solutions. Heilmann will lead the newly formed division to achieve its mission of enabling scientists to access, discover and develop revolutionary drugs and diagnostics by providing cutting-edge solutions that transform scientific ideas into reality.
"Laurie is a dynamic and visionary leader with an impressive record of success building and accelerating innovative biotechnology companies on a global scale," said Jean-Pierre Wery, Ph.D., Crown Bioscience Chief Executive Officer. "As President of CrownBio Global Life Science and Diagnostic Solutions Division, Laurie will spearhead strategy development and commercialization of a unique portfolio of products and services that supports clinical and diagnostic markets across several therapeutic concentrations, including oncology, inflammation, cardiovascular, metabolic and neurological diseases."
"This is an exciting opportunity to propel CrownBio Global Life Science and Diagnostic Solutions to a market leader position in life science and diagnostic spaces," said Laurie Heilmann, former Chief Business Officer at Crown Bioscience. "It is a pivotal time in the industry as we move forward with game-changing products and services that support research from concept through commercialization and enable scientists to access, discover and develop innovative drugs and diagnostics across several therapeutic areas."
Laurie possesses a diverse therapeutic background and has over three decades of global experience aligning sales and marketing with R&D to steer company strategy. As President of CrownBio Life Science Products and Diagnostics, Laurie will be responsible for charting new inroads of scientific and technological advancements to meet the needs of clinical and diagnostic markets across several therapy areas.
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation, and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
Crown Bioscience Inc. firstname.lastname@example.org
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
Corel14.8.2018 15:12 | pressemeddelelse
Pinnacle Studio 22 Ultimate Amps Up Video Editing with New Pro-inspired Features
Meltwater14.8.2018 15:01 | pressemeddelelse
Meltwater launches data science platform Fairhair.ai to tame real-time market signals found in world’s online data
Crown Bioscience14.8.2018 14:01 | pressemeddelelse
CrownBio Expands Genetically Engineered Model Selection Via Strategic Alliance with Shanghai Model Organisms Center (SMOC)
Mash Group Oyj13.8.2018 08:01 | pressemeddelelse
Mash Group Plc reports interim unaudited financials, H1 2018 ended 30th June 2018
ATPCO13.8.2018 06:01 | pressemeddelelse
ATPCO Awarded Patent for Cacheless Airline Ticket Pricing Model
XBiotech Inc.10.8.2018 14:02 | pressemeddelelse
XBiotech Highlights Quarterly Developments
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum